• Future Medicine’s K-OTC KONEX-listed common shares resume trading Oct. 1 as liquidation trading begins ahead of delisting.
• Liquidation trading runs Oct. 1–Oct. 13.
• Delisting is set for Oct. 14.
• The delisting trigger was failure to sign a new designated adviser contract within 30 days of termination, by Sept. 28.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Future Medicine Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20260929600830), on September 29, 2026, and is solely responsible for the information contained therein.